Study ID: C26401/1111 | 2013-001883-51

Study Title

Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Teva Identifier

C26401/1111 | 2013-001883-51

ClinicalTrials.gov Identifier

NCT01903824

Study Status

Completed

Trial Condition(s)

לשלוח לינק למוצר החדש - למורן

Interventions

Drug: CEP-26401 | Drug: donepezil hydrochloride | Drug: modafinil | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 50 Years

Trial Duration

08/01/2013 - 12/01/2013

Phase

Phase 1

Study Type

Interventional